Speaker: Peter Yates, Ph.D, Product Management Director, Personalized Medicine
As cell therapies quickly advance from pre-clinical stage into clinical and commercial applications, the design and implementation of scalable manufacturing platform technologies continues to be a focus for the field. Despite the successful commercialization of several cell therapies, bottlenecks in manufacturing throughput and capacity continue to hinder patient access to these life-saving treatments.
This webinar explores the current landscape and limitations of cell therapy manufacturing platforms and shares insights into how to choose a technology platform that assures flexibility in process development and scalability for clinical and commercial success.
- Challenges and opportunities associated with current cell therapy manufacturing platforms
- The flexibility of translating CAR T manufacturing processes to the Lonza Cocoon® Platform
- How to ensure process flexibility that enables rapid implementation of iterative manufacturing improvements
You will learn about: